Evidence map›Paper›PMID 38781393›Full record

ArticleScience (New York, N.Y.)2024

Systems biology dissection of PTSD and MDD across brain regions, cell types, and blood.

Nikolaos P Daskalakis, Artemis Iatrou, Chris Chatzinakos, Aarti Jajoo, Clara Snijders, Dennis Wylie, Christopher P DiPietro, Ioulia Tsatsani, Chia-Yen Chen, Cameron D Pernia and 37 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Integrative Transcriptomics and Machine Learning NominateInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. MECP2Science China. Life sciences · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Fine mapping of PTSD GWAS reveals a role for amygdalabioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Post-traumatic stress disorder.Nature reviews. Disease primers · 2026
    Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Nikolaos P DaskalakisMcLean Hospital, Belmont, MA 02478, USA.
Artemis Iatrou *McLean Hospital, Belmont, MA 02478, USA.
Chris Chatzinakos *McLean Hospital, Belmont, MA 02478, USA.
Aarti Jajoo *McLean Hospital, Belmont, MA 02478, USA.
Clara Snijders *McLean Hospital, Belmont, MA 02478, USA.
Dennis Wylie *Center for Biomedical Research Support, The University of Texas at Austin, Austin, TX 78712, USA.
Christopher P DiPietro *McLean Hospital, Belmont, MA 02478, USA.
Ioulia Tsatsani *McLean Hospital, Belmont, MA 02478, USA.
Chia-Yen Chen *Biogen Inc., Cambridge, MA 02142, USA.
Cameron D Pernia *McLean Hospital, Belmont, MA 02478, USA.
Marina Soliva-Estruch *McLean Hospital, Belmont, MA 02478, USA.
Dhivya Arasappan *Center for Biomedical Research Support, The University of Texas at Austin, Austin, TX 78712, USA.
Rahul A Bharadwaj *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Leonardo Collado-Torres *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Stefan Wuchty *Departments of Computer Science, University of Miami, Miami, FL 33146, USA.
Victor E Alvarez *Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Eric B Dammer *Department of Biochemistry, Center for Neurodegenerative Disease, Emory School of Medicine, Atlanta GA 30329, USA.
Amy Deep-Soboslay *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Duc M Duong *Department of Biochemistry, Center for Neurodegenerative Disease, Emory School of Medicine, Atlanta GA 30329, USA.
Nick Eagles *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Bertrand R Huber *Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Louise Huuki *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Vincent L Holstein *McLean Hospital, Belmont, MA 02478, USA.
Mark W Logue *National Center for PTSD, VA Boston Healthcare System, Boston, MA 02130, USA.
Justina F Lugenbühl *McLean Hospital, Belmont, MA 02478, USA.
Adam X Maihofer *Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, USA.
Mark W Miller *National Center for PTSD, VA Boston Healthcare System, Boston, MA 02130, USA.
Caroline M Nievergelt *Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, USA.
Geo Pertea *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Deanna Ross *Department of Psychology, University of Texas at Austin, Austin, TX 78712, USA.
Mohammad S E Sendi *McLean Hospital, Belmont, MA 02478, USA.
Benjamin B Sun *Biogen Inc., Cambridge, MA 02142, USA.
Ran Tao *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
James Tooke *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Erika J Wolf *National Center for PTSD, VA Boston Healthcare System, Boston, MA 02130, USA.
Zane Zeier *Department of Psychiatry & Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
PTSD Working Group of Psychiatric Genomics Consortium** *
Sabina BerrettaMcLean Hospital, Belmont, MA 02478, USA.
Frances A ChampagneDepartment of Psychology, University of Texas at Austin, Austin, TX 78712, USA.
Thomas HydeLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Nicholas T SeyfriedDepartment of Biochemistry, Center for Neurodegenerative Disease, Emory School of Medicine, Atlanta GA 30329, USA.
Joo Heon ShinLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Daniel R WeinbergerLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Charles B Nemeroff *Department of Psychology, University of Texas at Austin, Austin, TX 78712, USA.
Joel E Kleinman *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21205, USA.
Kerry J Ressler *McLean Hospital, Belmont, MA 02478, USA.
PTSD Working Group of Psychiatric Genomics Consortium

Funding

SPARED CenterP50MH115874 · NIMH · MCLEAN HOSPITAL · PI ROSSO, ISABELLE M · 2019 to 2023
$13.7M
Psychiatric Genomics Consortium for PTSDR01MH106595 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KARESTAN C KOENEN, Caroline M Nievergelt · 2016 to 2026
$8.4M
2/3 Understanding PTSD through Postmortem Targeted Brain Multi-omicsR01MH117291 · NIMH · LIEBER INSTITUTE, INC. · PI Joel Edward Kleinman · 2018 to 2026
$5.2M
Site 3/3, Understanding PTSD through Postmortem Targeted Brain MultiomicsR01MH117292 · NIMH · MCLEAN HOSPITAL · PI Nikolaos Daskalakis, KERRY J. RESSLER · 2018 to 2026
$5.0M
1/3 Understanding PTSD through Postmortem Targeted Brain Multi-omicsR01MH117293 · NIMH · UNIVERSITY OF TEXAS AT AUSTIN · PI CHARLES B NEMEROFF · 2018 to 2026
$4.3M
Training to Enhance Alignment of Psychiatry and NeuroscienceT32MH125786 · NIMH · MCLEAN HOSPITAL · PI William A. Carlezon, KERRY J. RESSLER · 2021 to 2026
$2.0M
Neuroimaging Genetics of PTSDR21MH102834 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MILLER, MARK W · 2014 to 2015
$355k
Genetic and Epigenetic Biomarkers of PTSDI01BX003477 · VA · VA BOSTON HEALTH CARE SYSTEM · PI LOGUE, MARK W · 2017 to 2020
–
BLRD VA I01 BX003477NIMH NIH HHS P50 MH115874NIMH NIH HHS R01 MH106595NIMH NIH HHS R01 MH117291NIMH NIH HHS R01 MH117292NIMH NIH HHS R01 MH117293NIMH NIH HHS R21 MH102834NIMH NIH HHS T32 MH125786RRD VA IK2 RX002922
6 · The paper itself

Abstract

The molecular pathology of stress-related disorders remains elusive. Our brain multiregion, multiomic study of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) included the central nucleus of the amygdala, hippocampal dentate gyrus, and medial prefrontal cortex (mPFC). Genes and exons within the mPFC carried most disease signals replicated across two independent cohorts. Pathways pointed to immune function, neuronal and synaptic regulation, and stress hormones. Multiomic factor and gene network analyses provided the underlying genomic structure. Single nucleus RNA sequencing in dorsolateral PFC revealed dysregulated (stress-related) signals in neuronal and non-neuronal cell types. Analyses of brain-blood intersections in >50,000 UK Biobank participants were conducted along with fine-mapping of the results of PTSD and MDD genome-wide association studies to distinguish risk from disease processes. Our data suggest shared and distinct molecular pathology in both disorders and propose potential therapeutic targets and biomarkers.

Indexed as

BrainGenetic LociMajor Depressive DisorderStress Disorders, Post-TraumaticAmygdalaBiomarkersChromosome MappingFemaleGene Regulatory NetworksGenome-Wide Association StudyHumansMaleNeuronsPrefrontal CortexSingle-Cell Gene Expression AnalysisSystems BiologyBiomarkers

Identifiers

PMID38781393
PMCPMC11203158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.